A recombinant FVIII to prevent and control bleeding in people with hemophilia A1
Novoeight®—designed
to fit into their world
RELIA BIL IT Y
0
INHIBITORS CONFIRMED1
One of the largest clinical trials with no inhibitors
confirmed in 213 previously treated patientsa,b
PU RITY
20
-NM FILTERS4
Employs state-of-the-art double nanofiltration
POR TA B IL IT Y
UP TO
David, 22 years old,
lives with hemoph